Vysum is a Melbourne born company set to improve the treatment delivery and management of eye conditions, starting with glaucoma, the world's second leading cause of blindness. We do this by providing users with a new experience of delivering eye medications more timely, accurately and comfortably. Administration data is recorded automatically and provided to clinicians to contribute to more informed treatment decisions. Since Vysum was founded in 2022, we have raised $92,000 capital including prizes, grants and private investment. This has enabled us to file our provisional and PCT patent applications, and producing a fully functional prototype.
